| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.093 | 0.1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |